SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-587129
Filing Date
2016-05-11
Accepted
2016-05-11 16:12:08
Documents
4
Period of Report
2016-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d194553d8k.htm 8-K 16123
2 EX-99.1 d194553dex991.htm EX-99.1 61110
3 EX-99.2 d194553dex992.htm EX-99.2 18426
4 GRAPHIC g194553image001.jpg GRAPHIC 2312
  Complete submission text file 0001193125-16-587129.txt   100274
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 161640017
SIC: 2834 Pharmaceutical Preparations